MedMira's rapid HIV test gets headstart in China
This article was originally published in Clinica
Executive Summary
Canadian in vitro diagnostics firm MedMira has beaten a path to a potentially lucrative market in China. The company has just become the first to gain State Drug Administration (SDA) approval for a rapid, point of care HIV test.